Table 1.

Baseline characteristics and treatment profile of subjects treated with Ritalin^® and Stimadate^®

	Ritalin® group	Stimdate® group	P.
Age; years old, Mean±SD	9.2±0.5	8.3±0.5	N.S.†
Gender			N.S.
Male, n	12	15
Female, n	3	0
Ethnicity	All Persian	All Persian	N.S.
Final treatment dose; mg, Mean±SD	29.2±9.1	31.4±8.6	N.S.
Number of side effects n, Mean±SD	1.6±1.5	2.1±2.5	N.S.

†N.S.: Not Significant